Lung Cancer

Palliative Care Considered Beneficial, Though Infrequently Used in Lung Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 4, 2021

A team of international investigators deployed a survey to understand the needs of patients with EGFR-positive lung cancer community.

Cosela Now Available to Reduce Chemotherapy-Induced Bone Marrow Suppression in ES-SCLC

By

Brian Park, PharmD

Publish Date March 3, 2021

The approval was based on data from 3 randomized, placebo-controlled trials that included 245 adults with ES-SCLC.

Keytruda Indication for Metastatic Small Cell Lung Cancer Withdrawn

By

Brian Park, PharmD

Publish Date March 3, 2021

Continued approval of the indication was contingent upon establishing the superiority of Keytruda as determined by overall survival.

Carboplatin Plus Nab-Paclitaxel and RT Promising for Advanced NSCLC in the Elderly

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 3, 2021

A team of investigators sought to determine outcomes from combination low-dose carboplatin plus nab-paclitaxel with concurrent radiotherapy among elderly patients with advanced non-small cell lung cancer.

Patient-Reported Outcomes With Lorlatinib in NSCLC

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 2, 2021

Although patient-reported outcomes measures were similar with lorlatinib and crizotinib in non-small cell lung cancer, more patients reported improvement in symptoms with lorlatinib.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)